Objective: The wide spread use of long-term enteral nutrition and the substantive costs dictate a need to study outcome, clinical and epidemiological characteristics of these patients. The aim of our study was to analyze incidence and characteristics of a cohort of patients on HEN during 6 years, after our previous pilot study of 3 years. Design: Prospective observational study. Setting: Tertiary care. Subjects: Between January 1999 and December 2004, all adult patients living in Valladolid West area who were discharged from the hospital on HEN were prospectively studied and followed up. Interventions: Information for each patient was prospectively recorded by the dietitian of the team, and include age, sex, body mass index, tricipital skinfold, midarm circumference, underlying disease, exitus, dates of initiation and discontinuation of HEN, nutrient formula, mode of administration and complications of HEN. During HEN, physicians supervised the home patients and the patients themselves or their close relative, were asked to contact our nutrition team if any problem occurred. Finally the yearly incidence of HEN was calculated each year on the basis of the estimated population in our area of recruitment, assuming almost all HEN patients were reported.
Introduction
Recent advances in enteral access techniques and devices made enteral feeding more acceptable to patients, their families, and physicians (Elia, 1995) . Although EN is generally require for several weeks, it does not justify keeping the patient in the hospital, with these basis home enteral nutrition (HEN) has increased it prevalence. During the past few years, HEN has gone through continuous growth, both because of its reliability and because of the National Health Services need to discharge chronic ill patients (Roberge et al., 2000) .
In the United States, the yearly prevalence of home enteral nutrition (HEN) was estimated at 415 per million populations (Howard et al., 1995) . The wide spread use of long-term enteral nutrition and the substantive costs dictate a need to study this nutritional therapy, clinical and epidemiological characteristics of these patients. In our country, HEN is regulated by a state law, creating a general organizational scheme. Our group (de Luis et al., 2003) have reviewed HEN in our area in the period [1999] [2000] [2001] , showing good results with this technique.
The aim of our study was to analyze incidence and characteristics of a cohort of patients on HEN during 6 years.
Materials and methods

Patients and indication
From January 1999 to December 2004, all adult patients living in Valladolid West area who were discharged from the hospital on HEN were prospectively studied and followed up. Informed consent was obtained in each patient.
The nutrition support team of the hospital (four doctors, which prescribed nutrition and evaluated complications, two nurses and one dietitian, which performed nutritional education and took nutritional parameters) supervised and discussed all indications of HEN. HEN was indicated for patients with oral failure, defined as an involuntary reduction in oral intake below the minimal amount necessary to maintain energy-protein requirements (o50% of daily adjusted by sex and age) with a functioning gut. HEN was administered via oral (patients with oral intake conserved), a nasogastric tube (NGT) (patients without oral tolerance less than 6 weeks), a percutaneous enteral gastrostomy tube (PEG) (patients without oral tolerance more than 6 weeks), or a jejunostomy tube (patients with mayor abdominal surgery). Polymeric or semi-elementary diets (fistulae, pancreatic disease, or inflammatory bowel disease) were used.
Four conditions had to be fulfilled to recommended HEN; (1) enteral nutrition had to be initiated in the hospital, shown to be well tolerated for a period of 5 days and the patient or a close relative had to be fully tained in the use of HEN, (2) the familial home environments had to be compatible with safe HEN delivery, (3) the patient's disease had to be sufficiently controlled and stable to allow home treatment, (4) the expected duration of HEN had to be at least one month.
Patients were divided in two groups in the analysis, group I (oral tolerance with supplements) and group II (enteral access with tube such as NGT, or PEG or jejunostomy).
Clinical characteristics
Information for each patient was prospectively recorded by the dietitian of the team, and include age, sex, weight, height, body mass index, tricipital skinfold, midarm circumference, underlying disease, exitus, dates of initiation and discontinuation of HEN, nutrient formula type, route of administration and complications of HEN. During HEN, physicians supervised the home patients and the patients themselves or their close relative, were asked to contact our nutrition team if any problem occurred. If patients or close relative did no contact with the team, review each 3 months in the Hospital.
Finally the yearly incidence of HEN was calculated each year on the basis of the estimated population in our area of recruitment, assuming almost all HEN patients were reported.
Anthropometric parameters
Body weight was measured to an accuracy of 0.5 Kg and body mass index computed as body weight/(height 2 ). Regional changes in body mass were estimated by measuring the circumferences and skinfold of the forearm.
Anthropometric and biochemical parameters
Fasting blood samples were drawn for measurement of albumin (3.5-4. 5 gr/dl), prealbumin (18-28 mg/dl), transferrin (250-350 mg/dl), and lymphocytes (1200-3500 Â 10 3 /ml) with an autoanalyzer (Hitachi, ATM, Manheim, Germany).
Statistical analysis
The results were expressed as mean7standard deviation. The distribution of variables was analyzed with KolmogorovSmirnov test. Quantitative variables with normal distribution were analyzed with two-factor repeated measures ANOVA including interaction terms. Non-parametric variables were analyzed using the Mann-Whitney U-test. Discrete variables were analyzed with the w 2 test, with Yates correction as necessary, and Fisher's test. Survival probabilities were estimated from Kaplan-Meier survival curves and compared by the log-rank test (time to event). The independent variable was survival and the explanatory variables were age, sex, diagnosis and nutrition via. Hazard ratios and 95% confidence intervals (95% CI) were calculated by multiple logistic regression model. A P-value under 0.05 was considered statistically significant. The mean age of all patients was 56.4717 years, without differences among years. The distribution of patients by diseases was; (43.8%) had a head and neck cancer, (26.8%) had human immunodeficiency virus infection, (9.6%) had a neurological disorders affecting swallowing (cerebrovacular accident and/or dementia), (4.7%) had diseases in digestive tract (fistulae, pancreatic disease, inflammatory bowel disease), (2.5%) had tumors in different locations with anorexia, (5%) had head trauma, and (7.6%) had one of several miscellaneous diseases inducing dysphagia or anorexia. HEN was administered via oral in 258 patients (70.6%) (group I), via a NGT in 95 patients (26.1%), a PEG in 9 patients (2.5%), and a jejunostomy in 3 patients (0.8%) (group II ¼ 107 patients) ( Table 1) .
Results
Patients and safety
The diet was a normocaloric and polymeric formula in 22.4% patients, a hypercaloric and polymeric in 5.2% patients, a hyperproteic and polymeric in 16.1% patients, a semielementary formula in 1.7% patients, a formula enriched with dietary fiber 2.3% and an immunomodulatory formula in 52.3% patients. In patients with no oral administration, the infusion was continuos in 11 patients (3%), cyclic in 9 patients (2.5%) and by bolus in 87 patients (23.8%). In all patients nutrients were administered by gravity. A total of 10 patients (3.7%) were rehospitalized after starting HEN, for a complication of enteral nutrition, mainly tube replacement or blockage. During the course of HEN, 12 patients had diarrhea (3.3%) and 8 (2.2%) constipation, and 4 vomiting (1.1%) that did not require cessation of HEN. No lung aspiration was detected. Hypernatremia (sodium 4145 meq/l) appeared only in six cases (1.64%) and 12 cases of hyperglycaemia (3.28%). Ten patients (2.8%) reported a least one problem with the tube. HEN was stopped because of HEN intolerance in 33 patients (tube intolerance (31), and psycologcical intolerance (30)).
No infection, leakage and bleeding were detected in tube site. Table 2 shows the results of several biochemical indices of nutrition status. Albumin, prealbumin, transferrin and lymphocytes improved in the both groups, when compared first revision with the last. Lymphocytes, albumin and transferrin were higher in group II than group I. Table 3 shows improvement of weight, tricipital skinfold and midarm circumference in the both groups. Weight, tricipital skinfold and midarm circumference were higher in group I than group II. No differences were detected in biochemical and anthropometric parameters among different groups of diseases.
Biochemical and anthropometric parameters
Outcomes
The mean duration of HEN was 148.2 þ 104 days. After the follow-up, 19 of the 365 patients (5.2%) had died, 346 (94.8%) were alive. ANOVA test did not show differences among groups in survival rate. Survival probability was influenced by the age. In multivariant analysis, an independent factor associated with death was age (hazard ratio: 1.22; 95% CI: 1.06-1.39), adjusted by sex , route and diagnosis. At the end of the study registration, 172 (47.2%) patients were able to resume enough oral intake that the enteral support could be discontinued and 47.8% continued receiving enteral nutrition support.
Discussion
Our study address an incidence of HEN between 26.5 and 9.5 per 100 000 inhabitants, these currents incidences are higher than the median incidence reported in a European survey 13.5 patients per 10 000 inhabitants (Hebuterne et al., 1999) . We don't have a clear reason to explain incidence differences among years. In our country the consumption of products of home enteral nutrition financed by the National System of Health, has experimented a remarkable increment (Castano Escudero and Perez Garbada, 2004) . Use of HEN in the US is much more frequent than in European countries (Howard et al., 1995) . Perhaps these differences are due to recognized differences in medical practice and economic factors (Elia, 1995) .
As in many other studies, dysphagia related to neurologic impairment of swallowing, or head and neck cancer, was the major indication for HEN. In the first Spain National register, the most common indication for HEN is neoplasias (39%), too (Gomez Candela et al., 1999) and the second most common indications is neurological disorders. In the last National register, 43.4% of patients were diagnosed with neurological disorders and 33.5% with cancer (Planas et al., 2004) . An important group of HEN has been patients infected with HIV (Greif and Golden, 1995) . In our study the death rate (5.2%) was lower than the Spain National register 17%. The most common access route was oral, followed by a nasogastric tube, PEG and jejunostomy, these results are equal than reported in our country (Castillo Rabaneda et al., 1998; Gomez Candela et al., 1999; Planas et al., 2004) .
Enteral nutrition was well tolerated and was able to provide complete nutrition in our population and complications occurred in a low percentage of the patients. The gastrointestinal complications were comparable to rates in other studies (Hull et al., 1993) . In our study, no aspiration pneumonias occurred, others studies showed a high incidence of aspiration pneumonia (Bordel-Marchasson et al., 1997; Nehra et al., 1999) , perhaps these differences are due to the good consciousness and ability to perform and comprehend daily activities of our patients with a low average age and the low rate of neurological disorders (less than 10%) in our study. Other studies have been detected the same data (Midorikawa et al., 2003) . All the deaths in these series were caused by the underlying illness.
Overall, HEN patients had a good outcome, and the mortality rate was low, in other studies HEN patients had a poor outcome (Schneider et al., 2001 ), an explanation is the different age and primary pathologies in these patients, our patients had a median age of 50 years, 20 years younger than other studies. However, nearly 70-80% of them had discontinuation HEN, emphasizing in this group the important role provided by the nutrition support team to repeat evaluations to determine wheter improvements in swallowing allow the discontinuation of enteral nutrition. The efficacy of HEN requires more frequent monitoring, reassessment, an intervention from a highly skilled multidisciplinary team that includes dietitians (Silver et al., 2004) .
Recently, some studies have reported poor outcome in some patients on HEN (Wicks et al., 1992) , in our study no differences were detected among diagnosis groups, however a better improvement in biochemical and anthropometric parameters in group I (only oral supplements). Qualitative studies have been performed to detect improvement in everyday life (Lilley and Manthorpe, 2003) .
In conclusion, HEN has a high incidence in our area and it is a valid and safe technique for nutrition support.
